Actinobaculum schaalii is a Gram-positive facultative anaerobe bacillus. It is a commensal organism of the genitourinary tract. Its morphology is nonspecific. Aerobic culture is tedious, and identification techniques have long been inadequate. Thus, A. schaalii has often been considered as a nonpathogen bacterium or a contaminant. Its pathogenicity is now well described in urinary tract infections, and infections in other sites have been reported. This pathogen is considered as an emerging one following the growing use of mass spectrometry identification. In this context, the aim of our study was to evaluate the number of isolations of A. schaalii before and after the introduction of mass spectrometry in our hospital and to study the clinical circumstances in which isolates were found.
Introduction
Actinobaculum schaalii is a Gram-positive bacillus that was described for the first time in 1997 [1] . Other species described in the same genus include Actinobaculum suis, Actinobaculum urinale and Actinobaculum massiliense. A. suis has been reported as a veterinary pathogen [2, 3] . A. urinale is rarely found in human infections but has been coisolated with A. schaalii [4] . Recent changes in the classification were made, reclassifying A. schaalii as Actinotignum schaalii [5] . It is a nonsporulated bacillus. Its morphology is nonspecific, and it sometimes looks like immobile corynebacteria. It is facultative anaerobic, which implies a possible anaerobic culture and culture in atmosphere supplemented with 5% CO 2 . Its aerobic culture is tedious and is facilitated by the use of bloodenriched media. These characteristics explain the difficulty of isolation, especially from urine, which is routinely incubated aerobically on unsupplemented media, such as chromogenic ones. A. schaalii is described as a commensal of the urogenital tract also found on the skin [6] . Many cases of infections have been reported, and urinary tract infections (UTIs) seem to predominate, particularly among elderly patients [7, 8] . However, other types of infections exist. Since its discovery, the number of reported isolates and clinical cases is increasing. It is thus considered to be an emerging pathogen.
The aim of our study was to assess retrospectively the frequency and circumstances of isolation of A. schaalii over 10 years in CH Versailles (France) and the role of matrixassisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) in the identification of this bacterium.
Materials and Methods
Using SIRScan software (I2A), we extracted all A. schaalii strains between July 2004 and February 2015. Strains were identified by sequencing of the 16S ribosomal DNA from colonies using the primers A2 (5 0 -AGAGTTTGAT-CATGGCTCAG-3 0 ) and S15 (5 0 -GGGCGGTGTGTA-CAAGGCC-3 0 ) [9] Clinical observations of all cases were reviewed to determine the pathogenic role of the isolate. The following informations were collected: age, sex, infection risk factors, site and isolation circumstances. We considered that A. schaalii was a pathogen when it was clearly mentioned in the actual benefit account and/or when it was the only bacteria isolated from the infectious site.
Results
Between July 2004 and February 2015, a total of 24 A. schaalii isolates were collected from 24 patients. Six isolates were initially identified by sequencing, and the other 18 were identified by MALDI-TOF. Among the six isolates initially identified by sequencing, three were further confirmed by MS. The results of the different scores obtained are shown in Table 1 . For isolates identified by MS, the statistical averages of the scores obtained for each of the first three proposed identifications are shown in Fig. 1 .
The circumstances of isolation and the clinical characteristics of the patients are summarized in Table 2 . Strains 
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were predominantly isolated from abscesses and collections (58% of cases, 14 isolates): bone infections and soft tissue infections including cysts and abscesses (wall, pilonidal sinus, breast, ankle etc.). The urine samples corresponded to 33% of the isolates: eight cases, including seven cases after November 2011 (Table 3) . Finally, blood cultures represented two isolates. Urine and blood cultures were monomicrobial, while 64% (9/14) abscesses and collections were plurimicrobial. The male/female sex ratio of the 24 patients was 1.2 with a mean age of 58.2 years (range, 8-96 years). In 75% of cases, at least one risk factor for infection was present, including age >65 years, immunosuppression, abnormality of the genitourinary tract and diabetes.
Discussion
Introduction of MALDI-TOF in clinical practice has led to an increase in the frequency of A. schaalii isolates in our laboratory (Table 3) . Indeed, between July 2004 and November 2011, six strains of A. schaalii were identified by sequencing, vs. 18 isolates by MS since November 2011. The most likely explanation is that before November 2011, routine bacterial identification was performed by biochemical tests such as API strips (bioMérieux, Marcy l'Etoile, France) or Vitek cards (bioMérieux). These techniques did not permit the identification of A. schaalii because this organism was then not included in the database [10] ; the latest 2015 version of the map Vitek anaerobe and Corynebacterium (ANC) now allows its detection.
Analysis of the results of identification by MS ( Fig. 1 ) revealed that the first three proposals correspond to the three spectra of A. schaalii of Bruker base (Table 4) in 17 of 18 cases, with a median identification score of 2.045 (1.82 to 2.26) for the first proposal. The three other Actinobaculum species in the database are never proposed. In addition, retrospective MS performed on three isolates stored and previously identified by 16S ribosomal DNA sequencing was successful for identification. As previously described [10] , we confirmed the identification performance by Microflex MALDI-TOF (Bruker) for A. schaalii with the three strains also identified by sequencing. However, it was reported that the MALDI-TOF Vitek (bioMérieux) does not currently allow the identification of A. schaalii [11, 12] . The pathogenic role of A. schaalii was not accepted by clinicians in two cases of bacteraemia because another recognized pathogen was isolated from blood cultures for each of the two patients. In addition, the presence of this microorganism as a contaminant of blood cultures suggests a possible presence on the skin [6] . Nevertheless, we cannot exclude its participation in the infection.
Urine samples all exhibited significant leukocyturia (>10 4 / mL), a positive direct microscopic examination with Grampositive bacilli and monomicrobial culture >10 5 CFU/mL. The isolation in urine requires seeding on a blood agar in atmosphere enriched in CO 2 . This is routinely carried out in our laboratory on urine samples with leukocyturia (>10 4 /mL) and Gram-positive bacilli on microscopic examination. The collected clinical data are consistent with a diagnosis of infection of the urogenital tract. A. schaalii is thus responsible for UTI in eight cases. One or more risk factors were found in these patients, highlighting the opportunistic nature of the microorganism. Advanced age is one of those risk factors (seven of eight patients were aged >65 years) with urinary infection of A. schaalii. However, infections in young subjects should not be excluded [13] , as evidenced by case of acute pyelonephritis in a 8-year-old patient.
To assess the clinical relevance of A. schaalii, its isolation in urine samples must be associated with symptoms of UTI because it is important to remember that it can sometimes be a urinary commensalism. As such, a prospective Danish study showed that A. schaalii could be detected by PCR in urine in more than 22% of patients aged >60 years, despite the absence of clinical signs in certain cases [14] . This may explain why A. schaalii is often reported to exist within polymicrobial urine [15] . In our practice, when there is a dominant uropathogen, the other possibly associated bacteria are not always identified, as they are considered commensal.
For abscesses and collections, we distinguish between mono-and plurimicrobial samples. Accountability is questionable for samples with various microorganisms. It is easier when there are no other related bacteria. This is the case of a 34-year-old patient with recurrent breast abscess, in which A. schaalii was clearly implicated, as specified in the medical report. As in most of the cases we have described, the patients were treated by surgery only without antibiotics, and the outcome was always good, suggesting that, unlike UTIs, antibiotic treatment is not routinely required to treat the infection. We emphasize that compared to urinary isolates, the age of the patient is more important for abscesses and collection. Another difference concerns young patients without risk factors, including an abdominal wall abscess in a 23-year-old patient, a pilonidal sinus abscess in a 20-year-old man and breast abscesses observed in a 34-year-old patient. However, it was suggested that A. schaalii could contribute to the infectious process even when it is isolated in the presence of other bacteria [15] . Cases of endocarditis [16] , Fournier gangrene [17] , spondylitis [18] and urosepsis [19] have already been reported, underscoring the invasive potential of this microorganism.
Overall, although UTIs are the most frequently reported in the literature [12] , our study shows that the isolation of A. schaalii in abscesses and collections is common. The frequency of isolation has increased since the onset of use of MS in our laboratory. This suggests that the emerging nature of infections due to A. schaalii is probably attributable to gaps in methods for identifying in the daily microbiology before the era of MS.
To conclude, our study emphasizes the role of MALDI-TOF in the accurate identification of A. schaalii. This process, which is less-time consuming and less expensive than molecular biology, advantageously replaces biochemical tests in the identification of this organism. The emergence of this bacterium presumably is the result, at least in part, of an evolution in identification methods. This will permit a better understanding of the epidemiology of A. schaalii. The pathogenic role of A. schaalii is questionable in some cases. Further studies are therefore needed, especially on the cutaneous habitat and virulence of this bacterium, to better interpret its presence in a clinical sample. [13] , comme en témoigne le cas de pyélonéphrite aiguë chez un patient de 8 ans rapporté dans notre série. Les résultats sont toutefois à confronter avec la clinique, car il ne faut pas oublier qu'il peut parfois s'agir d'un commensalisme urinaire. A ce titre, une étude prospective danoise a montré qu'A. schaalii pouvait être détecté par PCR dans les urines chez plus de 22% des patients d'un âge supérieur à 60 ans, malgré l'absence de signes cliniques dans certains cas [14] . Ceci peut expliquer qu'A. schaalii soit souvent rapporté au sein d'urines polymicrobiennes [15] . Dans notre pratique, lorsqu'il y a un uropathogène dominant, les autres bactéries éventuellement associées ne sont pas toujours identifiées, étant considérées comme des commensales. Pour les abcès et les collections, nous distinguons les prélève-ments mono-et plurimicrobiens. L'imputabilité est discutable pour les prélèvements avec plusieurs germes. Elle est plus facile lorsqu'il n'y pas d'autres bactéries associées. C'est le cas de la patiente de 34 ans avec un abcès de sein récidivant, chez qui A. schaalii a été clairement incriminé, comme précisé dans le compte rendu médical. Comme dans la majorité des cas que nous avons décrits, le traitement a été uniquement chirurgical avec des suites favorables, suggérant que contrairement aux infections urinaires, un traitement antibiotique n'est pas systématiquement requis pour traiter l'infection. Nous pouvons souligner que comparée aux isolats urinaires, la dispersion des âges des patients est plus importante pour les abcès et les collections. Une autre différence est que des patients jeunes sans facteurs de risque sont concernés : abcès de paroi abdominale chez un patient de 23 ans, abcès de sinus pilonidal chez un homme de 20 ans ou encore un abcès de sein observé chez une patiente de 34 ans. Il a toutefois été suggéré qu'A. schaalii pourrait contribuer au processus infectieux même quand il est isolé en présence d'autres germes [15] . Nous pouvons rappeler qu'un cas d'endocardite [16] , une gangrène de Fournier [17] , une spondylodiscite [18] et un urosepsis [19] ont ainsi déjà été rapportés, ce qui souligne le potentiel invasif de ce germe. Au total, bien que les infections du tractus urinaire soient les plus fréquemment rapportées dans la littérature [12] , notre étude montre que l'isolement d'A. schaalii dans les abcès et collections est fréquent. La fréquence d'isolement a augmenté depuis l'apparition de la spectrométrie de masse dans notre laboratoire. Cela suggère que le caractère émergent des infections dues à A. schaalii est probablement imputable aux lacunes des méthodes d'identification dans la microbiologie quotidienne avant l'ère de la spectrométrie de masse.
Conclusion
En conclusion, notre étude souligne une nouvelle fois l'apport de la spectrométrie de masse dans l'identification d'A. schaalii. Moins fastidieuse et moins coûteuse que la biologie moléculaire, elle remplace avantageusement les tests biochimiques pour l'identification de ce germe. L'émergence de cette bactérie vient donc vraisemblablement en partie d'une évolution dans les méthodes d'identification. Ceci va permettre une meilleure compréhension de l'épidémiologie des infections à A. schaalii. Le rôle pathogène est quant à lui discutable dans certains cas. D'autres études sont ainsi nécessaires, notamment sur l'habitat cutané et la virulence de cette bactérie, pour mieux interpréter sa présence dans un prélèvement, en particulier lorsqu'il est plurimicrobien.
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